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Abstract
Background: Loss of chromosome 11q defines a subset of high-stage aggressive neuroblastomas.
Deletions are typically large and mapping efforts have thus far not lead to a well defined consensus
region, which hampers the identification of positional candidate tumour suppressor genes. In a
previous study, functional evidence for a neuroblastoma suppressor gene on chromosome 11 was
obtained through microcell mediated chromosome transfer, indicated by differentiation of
neuroblastoma cells with loss of distal 11q upon introduction of chromosome 11. Interestingly,
some of these microcell hybrid clones were shown to harbour deletions in the transferred
chromosome 11. We decided to further exploit this model system as a means to identify candidate
tumour suppressor or differentiation genes located on chromosome 11.
Results: In a first step, we performed high-resolution arrayCGH DNA copy-number analysis in
order to evaluate the chromosome 11 status in the hybrids. Several deletions in both parental and
transferred chromosomes in the investigated microcell hybrids were observed. Subsequent
correlation of these deletion events with the observed morphological changes lead to the
delineation of three putative regions on chromosome 11: 11q25, 11p13->11p15.1 and 11p15.3, that
may harbour the responsible differentiation gene.
Conclusion: Using an available model system, we were able to put forward some candidate
regions that may be involved in neuroblastoma. Additional studies will be required to clarify the
putative role of the genes located in these chromosomal segments in the observed differentiation
phenotype specifically or in neuroblastoma pathogenesis in general.
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Background
In addition to the well known group of high stage neurob-
lastomas with MYCN  amplification and 1p-deletion, a
second genetic subgroup of aggressive neuroblastomas
has been delineated. This subgroup is characterised by the
presence of 11q-deletions, often in association with 3p-
deletions [1-5]. Both subgroups typically present with
17q-gain or a normal chromosome 17 copy number,
which are the strongest independent genetic indicators of
poor prognosis [6]. Deletions of 11q mostly affect a large
distal part of the long arm. Only a few small deletions
have been identified which delineated a tentative SRO
(shortest region of overlap) at 11q23 between markers
D11S1340 and D11S1299, encompassing a region of
approximately 3 Mb [7]. More recently however, a neu-
roblastoma patient was reported with a constitutional
11q14.1-11q23.3 deletion that did not overlap with the
proposed SRO [8]. Consequently, the presumed localisa-
tion of the 11q neuroblastoma tumour suppressor gene
(or genes) remains ill defined, thus hampering the selec-
tion of positional candidate genes. For the 11q23 region
we proposed SDHD as a putative candidate neuroblast-
oma tumour suppressor, but only two bona fide muta-
tions could be identified[9].
In addition to the observed losses of 11q in neuroblast-
oma, the existence of a tumour suppressor gene on 11q
has also been supported by functional evidence obtained
by microcell mediated chromosome 11 transfer (MMCT)
experiments [10]. Although these studies were initially
aimed at investigating the role of chromosome 1p in
tumour suppression, the control chromosome 11 transfer
experiment unexpectedly produced clones with morpho-
logical features of differentiation. Introduction of chro-
mosome 11 induced a more flattened and adherent
morphology, with short neuritic processes, similar to the
changes seen after a few days of growth in the presence of
retinoic acid. As these microcell hybrids could be power-
ful models for the identification of candidate neuroblast-
oma suppressor or differentiation genes, we decided first
to determine the genetic status of the chromosome 11 in
the hybrid subclones prior to further experiments. To this
purpose, the parental NGP cell line and the microcell
hybrids after chromosome 11 transfer were analysed using
high-resolution arrayCGH (microarray based compara-
tive genomic hybridisation), FISH (fluorescence in situ
hybridisation) and microsatellite heterozygosity map-
ping. Following the identification of a region on chromo-
some 11 with altered copy number, we measured the
mRNA expression levels of genes in these regions in an
attempt to find altered gene expression related to neurite
outgrowth and differentiation.
Results
Morphological characterisation
The chromosome 11 status of the different microcell
hybrid subclones used in this study and the reported chro-
mosome 11 changes [10] are listed in Table 1. The mor-
phology of the cells was comparable to the phenotype
described by Bader and colleagues [10]. Cells of the paren-
tal cell line NGP.1A.TR1 (a tumour reconstitute of muta-
genised NGP cells [10]) were non-adherent, spheroid and
growing in cell clusters (Figure 1A). Subclones with an
apparently intact transferred chromosome 11
(MCH574c4, c11, c13), as well as the clone with reported
loss of a region on 11q (MCH574c10) exhibited features
of induced differentiation, with more flattened and adher-
ent cells and some short neuritic processes (Figure 1C).
Subclone MCH574c3 with reported loss of part of 11p
showed the same non-adherent phenotype as the parental
cell line NGP.1A.TR1 (Figure 1B).
Table 1: Chromosome 11 status and morphology of the microcell hybrids (MCH) obtained after chromosome 11 transfer in parental 
NGP.1A.TR1 cells as determined by Bader and colleagues [10] and in this study
microcell hybrid subclone 
(NGP.1A.TR1 + chr 11)
chromosome 11 status 
(in addition to parental NGP.1A.TR1 11q-loss)
morphology
Bader et al. [10] this study
MCH574c4,c11,c13 no additional changes del(11)(pterp15.1) more flattened, adherent cells, 
some short neuritic processes
MCH574c10 del(11)(q23.3) (MCT128.1, HBI 
18P2)
del(11)(pterp15.1) more flattened, adherent cells, 
some short neuritic processes
MCH574c3 del(11)(p15.5) (HRAS) del(11)(pterp15.1)
del(11)(pterp13)
del(11)(q25qter)
non-adherent, spheroid cells, 
growing in cell clustersBMC Genomics 2005, 6:97 http://www.biomedcentral.com/1471-2164/6/97
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Assessment of the organisation of the actin fibres using
phalloidin staining confirmed the presence of neurites
(and excluded stress fibres) in subclones MCH574c10 and
MCH574c11[11].
ArrayCGH based chromosome 11 copy number assessment
ArrayCGH was performed for NGP.1A.TR1, MCH574c3
and MCH574c10 cells. These hybridisations failed to pro-
vide evidence for the reported 11q-deletion in the trans-
ferred chromosome of microcell hybrid MCH574c10
(Figure 2). Unexpectedly, the distal region of the short
arm of one of the chromosomes 11 (11pter->11p15.1)
was deleted in both MCH574c3 and MCH574c10. Micro-
cell hybrid MCH574c3 presented with an additional
larger deletion of 11pter->11p13, as well as a third dele-
tion involving the most distal band (11q25->11qter) in
one of the chromosomes 11. Deletion of a single BAC
clone RP11-51B23 on 11p15.3 was detected in the paren-
tal NGP.1A.TR1 cells (Figure 2B). Thus far, this clone has
not been recognised as being involved in polymorphic
genomic deletions for this particular chromosomal region
(own observations and Ensembl clone list). Deletions
observed by arrayCGH were confirmed by FISH analysis
using one BAC clone selected in each observed deleted
region (RP11-734D5 on 11p15.3, RP11-48O9 on 11p13,
RP11-545G16 on 11q25). This FISH analysis demon-
strated that the 11pter->11p15.1 deletion was present in
all other subclones that were not analysed with arrayCGH,
i.e. MCH574c4, c11 and c13.
Microsatellite heterozygosity mapping
To determine which of the chromosomes 11 exhibited
loss of the 11pter->11p15.1, 11pter->11p13 and 11q25-
>11qter regions, microsatellite heterozygosity mapping in
conjunction with FISH analysis of metaphase spreads was
performed. Microsatellite markers D11S861 (on 11p15.2)
and D11S1324 (on 11p14.1) were tested on NGP.1A.TR1,
MCH574c3 and MCH574c10. These tests show that one
of the two parental chromosomes 11 had lost the 11pter-
>11p15.1 region, while the 11pter->11p13 segment was
lost in the transferred chromosome. FISH on metaphase
spreads (clone RP11-545G16 on 11q25 in combination
with RP11-206C1 on 11p15.1; clone RP11-709M17 on
11q25 in combination with clone RP11-4B7 on 11p15.2)
demonstrated that the 11q25->11qter deletion occurred
in the transferred chromosome 11, whereas the 11pter-
>11p15.1 deletion occurred in the normal parental
chromosome 11 (and not in the parental der(11)t(2;11))
(Figure 2).
Breakpoint delineation of chromosome 11 deletions
The position of the deletion breakpoints was confirmed or
refined by FISH analysis. The breakpoint of the
del(11)(q22.1qter) resulting from an unbalanced
translocation between chromosomes 2 and 11 in parental
Cell morphology of parental cell line NGP.1A.TR1 Figure 1
Cell morphology of parental cell line NGP.1A.TR1 (A) and 
chromosome 11 transferred subclone MCH574c3 (B) with 
non-adherent, spheroid cells, and subclone MCH574c10 (C) 
showing signs of induced differentiation such as short neuritic 
processesBMC Genomics 2005, 6:97 http://www.biomedcentral.com/1471-2164/6/97
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ArrayCGH results (log2 scale) of parental cell line NGP1A.TR1 and microcell hybrids MCH574c3 and MCH574c10 compared  to a normal female control, with reported (red) and newly detected (orange) chromosome 11 deletion events Figure 2
ArrayCGH results (log2 scale) of parental cell line NGP1A.TR1 and microcell hybrids MCH574c3 and MCH574c10 compared 
to a normal female control, with reported (red) and newly detected (orange) chromosome 11 deletion events, (A) parental cell 
line (NGP.1A.TR1), (B) MCH574c10 in which regional 11q-loss of the transferred chromosome 11 was reported [10] and (C) 
MCH574c3 with reported regional 11p-loss of transferred chromosome 11. FISH was used to confirm the results obtained by 
arrayCGH (data not shown).BMC Genomics 2005, 6:97 http://www.biomedcentral.com/1471-2164/6/97
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cell line NGP.1A.TR1 mapped within a 2.285 Mb segment
located between BAC clones RP11-379J13 and RP11-
49M9 (map position between 97.328 Mb and 99.613 Mb,
NCBI 35 May 2004 assembly (hg17)). The breakpoint of
the 11pter->11p15.1 deletion of the normal parental
chromosome 11 in all microcell hybrids was assigned to a
229 kb segment between RP11-452G18 and RP11-
358H18 (17.337 Mb – 17.596 Mb). The breakpoint of the
larger 11p-deletion (11pter->11p13) present in
MCH574c3 was located within a 921 kb segment flanked
by clones RP11-48O9 and RP11-202M19 (33.038 Mb –
33.959 Mb). The breakpoint of the distal ± 13 Mb 11q25-
>11qter deletion of the transferred chromosome in sub-
clone MCH574c3 was mapped between BAC clones
RP11-340L13 and RP11-697E14 (131.149 Mb – 131.230
Mb). Flanking clones of the 11p15.3 deletion in
NGP.1A.TR1 were also tested using FISH (RP11-734D5,
RP11-573E11, RP11-47J17) demonstrating that the dele-
tion involves at least a 707 kb segment including BAC
clones RP11-573E11 and RP11-47J17 (12.202 Mb –
12.909 Mb) (Figure 3).
mRNA expression profiling
As loss of 11q is a recurrent chromosomal aberration in a
subgroup of advanced stage neuroblastomas, the 11q25-
>11qter region that is deleted in the MCH574c3 microcell
hybrid is of particular interest. In an attempt to relate the
observed morphology of induced neuronal differentia-
tion to expression differences of genes located in this dis-
tal 11q25 segment, the expression of 6 known genes, i.e.
HNT, OPCML, JAM3, THY28, ACAD8 and B3GAT1 was
tested. Of particular interest are HNT  and  B3GAT1,
because of their reported involvement in neurite out-
growth and neural crest development. We quantified the
mRNA expression of these 6 genes in the microcell
hybrids, the parental cell line and in neuroblastoma cell
lines (SH-SY5Y, LA-N-5 and NTRK1 transfected SH-SY5Y)
that were treated with inducers of differentiation [12-14].
While the expression of the genes is not significantly
altered in the microcell hybrids compared to the parental
cell line, the expression of HNT is significantly higher in
different cell lines that are induced to differentiate
(between 5 to 120 fold induction) (Figure 4).
Discussion
In a search for candidate neuroblastoma genes located on
chromosome arm 11q, we investigated microcell hybrids
obtained by transfer of a normal chromosome 11 into
NGP neuroblastoma cells with loss of 11q. Although ini-
tially designed as a control experiment, this transfer
resulted in morphological changes in the obtained
hybrids (without loss of tumorigenicity) and also yielded
revertants after further culture [10]. The induced differen-
tiation that was observed in all but one microcell hybrid
is consistent with the presence of a neuroblastoma differ-
entiation gene on chromosome 11. We thus anticipated
that these hybrids might be of interest for functional map-
ping of the regions on chromosome 11 critically involved
in neuroblastoma pathogenesis. To investigate this, we
performed arrayCGH copy number analysis of these
FISH analysis of BAC clones RP11-573E11 (panel A), RP11- 51B23 and RP11-47J17 (not shown) in parental cells  NGP.1A.TR1 (with a derivative chromosome 11, due to an  unbalanced translocation between chromosomes 11 and 2)  confirms the existence of a small deletion in 11p15.3 Figure 3
FISH analysis of BAC clones RP11-573E11 (panel A), RP11-
51B23 and RP11-47J17 (not shown) in parental cells 
NGP.1A.TR1 (with a derivative chromosome 11, due to an 
unbalanced translocation between chromosomes 11 and 2) 
confirms the existence of a small deletion in 11p15.3. The 
breakpoint of the distal 11q25->11qter deletion of the trans-
ferred chromosome in subclone MCH574c3 was mapped 
between BAC clones RP11-340L13 (not shown) and RP11-
697E14 (panel B).BMC Genomics 2005, 6:97 http://www.biomedcentral.com/1471-2164/6/97
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microcell hybrids. This allowed us to assess the status of
the introduced (and parental) chromosomes 11 and to
validate these hybrids as model system for further
functional assays. The obtained results were surprising
and puzzling. One particular microcell hybrid that did not
show the expected differentiation features upon chromo-
some 11 transfer was shown to carry an 11q25->11qter
deletion in the transferred chromosome. In addition we
found that all microcell hybrid subclones presented with
an 11pter->11p15.1 deletion, and that the MCH574c3
hybrids presented with an additional 11pter->11p13
deletion.
In line with previous successful functional analyses of
microcell hybrids [15], the responsible gene for the
observed changes in cell morphology is assumed to be
located in one of the chromosomal regions that show a
different copy number in the microcell hybrid subclones
with differentiation features (MCH574c4, c10, c11 and
c13) compared to the non-adherent, spheroid cell pheno-
type of parental cell line NGP.1A.TR1 and microcell
hybrid subclone MCH574c3. Based upon our findings
three regions can be identified as candidate regions har-
bouring a putative differentiation gene: (1) the 11q25-
>11qter region (lost in MCH574c3), (2) the 11p13-
>11p15.1 region (lost in MCH574c3 but not in the other
MCH574 subclones) and (3) a small region of at least 706
kb on 11p15.3 (lost in NGP.1A.TR1) (Figure 5).
As loss of distal 11q is a recurrent chromosomal aberra-
tion in MYCN single copy advanced stage neuroblastomas
[3], we propose the 11q25->11qter chromosomal
segment as the most likely candidate region for the pres-
ence of a differentiation gene. Despite efforts to define a
shortest region of overlap (SRO) for 11q-loss in neurob-
lastoma by microsatellite heterozygosity mapping [7] and
delineation of constitutional 11q-deletions [8,16], a con-
sensus region for loss of 11q in neuroblastoma has not
Fold induction of HNT mRNA expression (log scale, versus control cultures, C) in neuroblastoma cell lines SH-SY5Y, LA-N-5  and NTRK1-transfected SH-SY5Y after induction of differentiation with RA and BDNF (retinoic acid and brain-derived neuro- trophic factor), NGF (nerve growth factor) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) Figure 4
Fold induction of HNT mRNA expression (log scale, versus control cultures, C) in neuroblastoma cell lines SH-SY5Y, LA-N-5 
and NTRK1-transfected SH-SY5Y after induction of differentiation with RA and BDNF (retinoic acid and brain-derived neuro-
trophic factor), NGF (nerve growth factor) and TPA (12-O-tetradecanoyl-phorbol-13-acetate).BMC Genomics 2005, 6:97 http://www.biomedcentral.com/1471-2164/6/97
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been defined thus far. In the light of the uncertainty of the
boundaries of the 11q SRO, the 11q25->11qter region
must be considered as potentially harbouring a neurob-
lastoma suppressor or differentiation gene. This region is
present in two copies in microcell hybrid subclones
MCH574c4, c10, c11 and c13 with differentiated mor-
phology, but only in one copy in the non-adherent, sphe-
roid cells from NGP.1A.TR1 and MCH574c3. Six known
Regional copy numbers (deletion events are indicated in red) in cells with non-adherent, spheroid (parental) cell phenotype  compared to cells with induced differentiation, demonstrating the three regions on chromosome 11 that may be involved in  the phenotypic difference, i.e. a small region on 11p15.3 encompassing BAC clone RP11-51B23 (lost in NGP.1A.TR1) (A  region), the 11p13->11p15.1 region (lost in MCH574c3 but not in the other MCH574 microcell hybrids) (B region) and the  11q25->11qter region (lost in MCH574c3) (C region) (* indicates the putative presence of a mutated gene) Figure 5
Regional copy numbers (deletion events are indicated in red) in cells with non-adherent, spheroid (parental) cell phenotype 
compared to cells with induced differentiation, demonstrating the three regions on chromosome 11 that may be involved in 
the phenotypic difference, i.e. a small region on 11p15.3 encompassing BAC clone RP11-51B23 (lost in NGP.1A.TR1) (A 
region), the 11p13->11p15.1 region (lost in MCH574c3 but not in the other MCH574 microcell hybrids) (B region) and the 
11q25->11qter region (lost in MCH574c3) (C region) (* indicates the putative presence of a mutated gene).BMC Genomics 2005, 6:97 http://www.biomedcentral.com/1471-2164/6/97
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genes, i.e. HNT,  OPCML,  JAM3,  THY28,  ACAD8  and
B3GAT1 are located in this distal 11q segment, of which
two genes are of particular interest. HNT (neurotrimin) is
reported to promote neurite outgrowth and adhesion
[17]. B3GAT1 encodes for a protein that functions as the
key enzyme in a glucuronyl transfer reaction during the
biosynthesis of the carbohydrate epitope HNK1 (CD57)
[18,19], which is a carbohydrate expressed in develop-
mentally immature neural crest cells [20]. Interestingly,
the expression of HNT is significantly increased in neu-
roblastoma cell lines that are induced to differentiate
using RA (retinoic acid), RA plus BDNF (brain-derived
neurotrophic factor), NGF (nerve growth factor) and TPA
(12-O-tetradecanoyl-phorbol-13-acetate). However, HNT
expression is not significantly different between the differ-
entiated microcell hybrids and the parental cells. It is con-
ceivable that the observed phenotypic changes are caused
by small changes in expression that can not be reliably
detected by Q-PCR. An alternative explanation is that the
normal parental chromosome 11 harbours a mutated
allele that is normally expressed at the mRNA level (Figure
5). Reintroduction of a wild type allele by chromosome
transfer could repair the defect, leading to differentiation.
This is in keeping with reversal to the non-adherent, sphe-
roid morphology of the microcell hybrids that have lost
the 11q25->11qter region of the transferred chromosome.
Additional mutation, promoter hypermethylation and
gene directed functional assays are needed to clarify which
of the genes located within the deleted 11q25->11qter
region are responsible for the differentiated phenotype.
While the 11q25 region is the best candidate region to
harbour a differentiation gene, the observed deletions on
the short arm of chromosome 11 may also account for the
differentiated morphology. The observation of two
independent deletion events along the distal part of chro-
mosome arm 11p is suggestive for the involvement of this
region. In particular, it is striking that all microcell hybrids
in which chromosome 11 is transferred are characterised
by the presence of an 11pter->11p15.1 deletion in the
(prior to transfer) normal parental chromosome 11. This
may either be the result of an early coincidental event dur-
ing the transfer process, or indicative for a selection proc-
ess against the presence of three copies of a growth
suppressive gene in this region. The last hypothesis may
be further supported by the presence of unbalanced 11p-
deletions in 4% of neuroblastomas (14/394) [21,22].
Apart from highlighting at candidate 11q regions involved
in neuroblastoma pathogenesis, this study clearly shows
that it is important to monitor the transfer of the desired
chromosome, as well as the genetic background of the cell
line before and after chromosome transfer experiments.
Selective pressure processes may occur during or after
transfer of a chromosome, e.g. by chromosomal loss in
order to maintain the viability of the microcell hybrids.
Hence, detailed information on the chromosome copy
number status before and after transfer is required in
order to correlate phenotypic changes with chromosomal
alteration. ArrayCGH has been proven to be a valuable
screening method for evaluation of the chromosome
alterations and for delineation of possible deletion events,
allowing fine-mapping of the candidate regions that har-
bour candidate suppressor genes.
Conclusion
Microsatellite marker heterozygosity analysis, FISH and
(array)CGH based copy number in neuroblastoma
tumour specimens and patients with constitutional dele-
tions have thus far not identified a consensus SRO for
11q-deletion. Here, we present an alternative strategy to
pinpoint chromosomal regions or genes that may be
important in neuroblastoma pathogenesis. Chromosome
11 transfer, followed by phenotype scoring and high-res-
olution copy number analysis delineated putative regions
on chromosome 11 involved in tumour differentiation.
Further mutation and functional analyses are required to
clarify the putative involvement of genes localised in these
regions in neuroblastoma.
Methods
Cell lines
The parental cell line, NGP.1A.TR1, and the chromosome
11 microcell transfer derived subclones MCH574c3, c4,
c10, c11 and c13 used in this study have been described
previously [10].
Cell lines were cultured following standard procedures
and were digitally photographed under an inverted
(phase-contrast) microscope, pelleted, snap-frozen and
stored at -80°C for further processing. DNA was isolated
using the QIAamp DNA mini kit (Qiagen). RNA was
isolated from the snap-frozen cell pellets using the RNeasy
Mini kit (Qiagen) according to the manufacturer's
guidelines, followed by RNase free DNase treatment on
column (Qiagen).
Culture conditions and details regarding differentiation
protocols are given in [12,13]. The NTRK1-transfected SH-
SY5Y cells used, were SH-SY5Y/trkA, clone 6:2 described
in [23].
Phalloidin staining
Cell lines were fixed for 10 min in 4% paraformaldehyde/
HEPES on ice. The excess of aldehydes is quenched for 5
min in 50 mM NH4Cl. After washing twice for 5 min in 1x
PBS, extraction is performed for 5 min in acetone (20°C).
The cells are washed again twice for 5 min in 1x PBS, fol-
lowed by blocking in 0.2% Fish Skin Gelatine (FSG,
Sigma)/PBS. During 60 min cells are incubated with AlexaBMC Genomics 2005, 6:97 http://www.biomedcentral.com/1471-2164/6/97
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594-phalloidin (1 unit per section), dissolved in
0.2%FSG/PBS at 37°C. Cells are washed twice for 5 min
in 1x PBS; nuclei are stained for 1 min with DAPI; sections
are washed with 1x PBS and mounted in Vectashield.
ArrayCGH
ArrayCGH using 1 Mb BAC arrays was performed once for
NGP.1A.TR1, MCH574c3 and MCH574c10 cells with
normal female DNA as control. In addition, subclones
MCH574c3 and MCH574c10 were hybridised to the same
arrays with NGP.1A.TR1 DNA as control. Hybridisation of
cell line and control DNA to the array was performed as
described [24]. Using our in-house developed analysis
and visualisation software, arrayCGHbase, data were nor-
malised to the median ratio, and replicate median ratio
profiles visualised http://medgen.ugent.be/arrayCGH
base   [29].
FISH and microsatellite marker analysis
BAC clones and microsatellite markers were selected
based on their chromosomal position using the Ensembl
genome browser http://www.ensembl.org, the UCSC
human genome browser (July 2003 freeze, http://
genome.ucsc.edu) or the Genome Database http://
gdbwww.gdb.org. Labelling and FISH (fluorescence in
situ hybridisation) was performed as described [25].
Experimental conditions for the fluorescent based micro-
satellite screening can be obtained from the authors upon
request.
Real-time quantitative RT-PCR based mRNA expression 
profiling
Primers were designed using Primer Express v2.0 (Applied
Biosystems). Primer sequences are available in the public
RTPrimerDB database http://medgen.UGent.be/
rtprimerdb/: HNT (1078), OPCML (1079), JAM3 (1080),
THY28 (1084), ACAD8 (1081), B3GAT1 (1082), HPRT1
(5), UBC (8) and GAPD (3) [26]. Relative expression lev-
els were determined using an optimized two-step SYBR
Green I RT-PCR assay [27]. PCR reagents were obtained
from Eurogentec as SYBR Green I core reagents, prepared
as 2x mastermixes, stored at -20°C and used according to
the manufacturer's instructions. Reactions were run on an
ABI5700 (Applied Biosystems). The comparative CT
method was used for quantification. Gene expression lev-
els were normalized using the geometric mean of the 3
most stable internal control genes in neuroblastoma (i.e.
UBC, HPRT1 and GAPD) as reported previously [28].
Abbreviations
arrayCGH = microarray based comparative genomic
hybridisation
FISH = fluorescence in situ hybridisation
MMCT = microcell mediated chromosome transfer
SRO = shortest region of overlap
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